User talk:Boghog

Difluanazine
Identifiers
	IUPAC name N-[2-[4-[4,4-bis(4-fluorophenyl)butyl]piperazin-1-yl]ethyl]aniline;
CAS Number	5522-39-4;
PubChem CID	21693;
ChemSpider	20389;
UNII	0G412821A8;
ChEMBL	ChEMBL2110931;
Chemical and physical data
Formula	C28H33F2N3
Molar mass	449.590 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1CN(CCN1CCCC(C2=CC=C(C=C2)F)C3=CC=C(C=C3)F)CCNC4=CC=CC=C4;
	InChI InChI=InChI=1S/C28H33F2N3/c29-25-12-8-23(9-13-25)28(24-10-14-26(30)15-11-24)7-4-17-32-19-21-33(22-20-32)18-16-31-27-5-2-1-3-6-27/h1-3,5-6,8-15,28,31H,4,7,16-22H2; Key:ITBCJAOQRBZXQE-UHFFFAOYSA-N;

If I have left you a message: please answer on your talk page, as I am watching it.
If you leave me a message: I will answer on my talk page, so please add it to your watchlist.
Please click here to leave me a new message.

Archives

This page has archives. Sections older than 30 days may be automatically archived by when more than 4 sections are present.

New Page Patrol newsletter October 2022

Hello Boghog,

Much has happened since the last newsletter over two months ago. The open letter finished with 444 signatures. The letter was sent to several dozen people at the WMF, and we have heard that it is being discussed but there has been no official reply. A related article appears in the current issue of The Signpost. If you haven't seen it, you should, including the readers' comment section.

Awards: Barnstars were given for the past several years (thanks to MPGuy2824), and we are now all caught up. The 2021 cup went to John B123 for leading with 26,525 article reviews during 2021. To encourage moderate activity, a new "Iron" level barnstar is awarded annually for reviewing 360 articles ("one-a-day"), and 100 reviews earns the "Standard" NPP barnstar. About 90 reviewers received barnstars for each of the years 2018 to 2021 (including the new awards that were given retroactively). All awards issued for every year are listed on the Awards page. Check out the new Hall of Fame also.

Software news: Novem Linguae and MPGuy2824 have connected with WMF developers who can review and approve patches, so they have been able to fix some bugs, and make other improvements to the Page Curation software. You can see everything that has been fixed recently here. The reviewer report has also been improved.

Suggestions:

There is much enthusiasm over the low backlog, but remember that the "quality and depth of patrolling are more important than speed".
Reminder: an article should not be tagged for any kind of deletion for a minimum of 15 minutes after creation and it is often appropriate to wait an hour or more. (from the NPP tutorial)
Reviewers should focus their effort where it can do the most good, reviewing articles. Other clean-up tasks that don't require advanced permissions can be left to other editors that routinely improve articles in these ways (creating Talk Pages, specifying projects and ratings, adding categories, etc.) Let's rely on others when it makes the most sense. On the other hand, if you enjoy doing these tasks while reviewing and it keeps you engaged with NPP (or are guiding a newcomer), then by all means continue.
This user script puts a link to the feed in your top toolbar.

Backlog:

Saving the best for last: From a July low of 8,500, the backlog climbed back to 11,000 in August and then reversed in September dropping to below 6,000 and continued falling with the October backlog drive to under 1,000, a level not seen in over four years. Keep in mind that there are 2,000 new articles every week, so the number of reviews is far higher than the backlog reduction. To keep the backlog under a thousand, we have to keep reviewing at about half the recent rate!

Reminders

Newsletter feedback - please take this short poll about the newsletter.
If you're interested in instant messaging and chat rooms, please join us on the New Page Patrol Discord, where you can ask for help and live chat with other patrollers.
Please add the project discussion page to your watchlist.
If you are no longer very active on Wikipedia or you no longer wish to be a reviewer, please ask any admin to remove you from the group. If you want the tools back again, just ask at PERM.
To opt out of future mailings, please remove yourself here.

New Pages Patrol newsletter January 2023

Hello Boghog,

Backlog

The October drive reduced the backlog from 9,700 to an amazing 0! Congratulations to WaddlesJP13 who led with 2084 points. See this page for further details. The queue is steadily rising again and is approaching 2,000. It would be great if <2,000 were the “new normal”. Please continue to help out even if it's only for a few or even one patrol a day.

2022 Awards

Onel5969 won the 2022 cup for 28,302 article reviews last year - that's an average of nearly 80/day. There was one Gold Award (5000+ reviews), 11 Silver (2000+), 28 Iron (360+) and 39 more for the 100+ barnstar. Rosguill led again for the 4th year by clearing 49,294 redirects. For the full details see the Awards page and the Hall of Fame. Congratulations everyone!

Minimum deletion time: The previous WP:NPP guideline was to wait 15 minutes before tagging for deletion (including draftification and WP:BLAR). Due to complaints, a consensus decided to raise the time to 1 hour. To illustrate this, very new pages in the feed are now highlighted in red. (As always, this is not applicable to attack pages, copyvios, vandalism, etc.)

New draftify script: In response to feedback from AFC, the The Move to Draft script now provides a choice of set messages that also link the creator to a new, friendly explanation page. The script also warns reviewers if the creator is probably still developing the article. The former script is no longer maintained. Please edit your edit your common.js or vector.js file from User:Evad37/MoveToDraft.js to User:MPGuy2824/MoveToDraft.js

Redirects: Some of our redirect reviewers have reduced their activity and the backlog is up to 9,000+ (two months deep). If you are interested in this distinctly different task and need any help, see this guide, this checklist, and spend some time at WP:RFD.

Discussions with the WMF The PageTriage open letter signed by 444 users is bearing fruit. The Growth Team has assigned some software engineers to work on PageTriage, the software that powers the NewPagesFeed and the Page Curation toolbar. WMF has submitted dozens of patches in the last few weeks to modernize PageTriage's code, which will make it easier to write patches in the future. This work is helpful but is not very visible to the end user. For patches visible to the end user, volunteers such as Novem Linguae and MPGuy2824 have been writing patches for bug reports and feature requests. The Growth Team also had a video conference with the NPP coordinators to discuss revamping the landing pages that new users see.

Reminders

Newsletter feedback - please take this short poll about the newsletter.
There is live chat with patrollers on the New Page Patrol Discord.
Please add the project discussion page to your watchlist.
If you no longer wish to be a reviewer, please ask any admin to remove you from the group. If you want the tools back again, just ask at PERM.
To opt out of future mailings, please remove yourself here.

New Pages Patrol newsletter June 2023

Hello Boghog,

Backlog

Redirect drive: In response to an unusually high redirect backlog, we held a redirect backlog drive in May. The drive completed with 23851 reviews done in total, bringing the redirect backlog to 0 (momentarily). Congratulations to Hey man im josh who led with a staggering 4316 points, followed by Meena and Greyzxq with 2868 and 2546 points respectively. See this page for more details. The redirect queue is steadily rising again and is steadily approaching 4,000. Please continue to help out, even if it's only for a few or even one review a day.

Redirect autopatrol: All administrators without autopatrol have now been added to the redirect autopatrol list. If you see any users who consistently create significant amounts of good quality redirects, consider requesting redirect autopatrol for them here.

WMF work on PageTriage: The WMF Moderator Tools team, consisting of Sam, Jason and Susana, and also some patches from Jon, has been hard at work updating PageTriage. They are focusing their efforts on modernising the extension's code rather than on bug fixes or new features, though some user-facing work will be prioritised. This will help make sure that this extension is not deprecated, and is easier to work on in the future. In the next month or so, we will have an opt-in beta test where new page patrollers can help test the rewrite of Special:NewPagesFeed, to help find bugs. We will post more details at WT:NPPR when we are ready for beta testers.

Articles for Creation (AFC): All new page reviewers are now automatically approved for Articles for Creation draft reviewing (you do not need to apply at WT:AFCP like was required previously). To install the AFC helper script, visit Special:Preferences, visit the Gadgets tab, tick "Yet Another AFC Helper Script", then click "Save". To find drafts to review, visit Special:NewPagesFeed, and at the top left, tick "Articles for Creation". To review a draft, visit a submitted draft, click on the "More" menu, then click "Review (AFCH)". You can also comment on and submit drafts that are unsubmitted using the script.

You can review the AFC workflow at WP:AFCR. It is up to you if you also want to mark your AFC accepts as NPP reviewed (this is allowed but optional, depends if you would like a second set of eyes on your accept). Don't forget that draftspace is optional, so moves of drafts to mainspace (even if they are not ready) should not be reverted, except possibly if there is conflict of interest.

Pro tip: Did you know that visual artists such as painters have their own SNG? The most common part of this "creative professionals" criteria that applies to artists is WP:ARTIST 4b (solo exhibition, not group exhibition, at a major museum) or 4d (being represented within the permanent collections of two museums).

Reminders

Newsletter feedback - please take this short poll about the newsletter.
There is live chat with patrollers on the New Page Patrol Discord and #wikimedia-npp ^connect on IRC.
Please add the project discussion page to your watchlist.
To opt out of future mailings, please remove yourself here.

New pages patrol May 2025 Backlog drive

May 2025 Backlog Drive \| New pages patrol
On 1 May 2025, a one-month backlog drive for New Pages Patrol will begin. Barnstars will be awarded based on the number of articles patrolled. Barnstars will also be granted for re-reviewing articles previously reviewed by other patrollers during the drive. Each review will earn 1 point. Interested in taking part? Sign up here.
You're receiving this message because you are a new page patroller. To opt-out of future mailings, please remove yourself here.

MediaWiki message delivery (talk) 15:24, 24 April 2025 (UTC)[reply]

Disambiguation link notification for May 1

An automated process has detected that when you recently edited Corticotropin-releasing hormone receptor, you added links pointing to the disambiguation pages IP3 and DAG.

(Opt-out instructions.) --DPL bot (talk) 07:56, 1 May 2025 (UTC)[reply]

Edit request for Reshma Kewalramani

Hi Boghog. I am reaching out to you because you have helped out with edit requests for Jeffrey Leiden and Vertex Pharmaceuticals. Currently, I have posted an edit request for a related page, for the CEO of Vertex, Reshma Kewalramani here: Talk:Reshma Kewalramani#Second paragraph of Career section update. I hope you can take a look, and if you agree that the edits are appropriate, please implement them. Thanks again for all your past interest and help. JohnDatVertex (talk) 15:41, 8 May 2025 (UTC)[reply]

A really big thank you to this editor from me🤗✌️

Just a quick but just more bigger and sincerely ment thank you for tuning up my edit-block about benperidole, written from the editor or originator of this edit🤗✌️

You made my writing, just way more better in every possible regard, this especially If you would not have some specific expertise in pharmacoligy woud made your generall expertise (and also, for sure, though with being a pharmacoligicall expert) It is one thing to oversee his own editperformings, but to be this intelligent to oversee one others content of mind this exceptfully perfect to really improve one others edit to every considerable way, is intelligence on a brutally another level, my deepest respects for this, mylord!🤗

Infact was my benperidole-edit one of my own considered less well performings, which I did rereading with more of an average excitement in some sort of ways, yet after your improvements, this edit does give me a significant more pleasure when I reread or seeking out for this edit.

Flawless way of an extreme form of intelligence in my opinion (honestly ment), did you ever considered to join high IQ-leagues, and I am not speaking about the basement mensa-niveau in your terms, I speak about the chief-societies beginning of a performingseperation of at least a score beginning with 170.

Nevertheless,do I wish you a great rest of todays evening and a just greater start into the weekend for you, greetings from me!🤗🤗🤗✌️ 78.94.198.245 (talk) 21:50, 8 May 2025 (UTC)[reply]

Thanks for your message. I really appreciate it. I'm glad the edits were helpful, and it was a good base to work from. Hope you have a good weekend too. Boghog (talk) 17:05, 9 May 2025 (UTC)[reply]

thank you🤗✌️ 2001:9E8:90B5:F300:D1BB:BB94:DBE5:B6CE (talk) 00:04, 10 May 2025 (UTC)[reply]

Disambiguation link notification for May 13

An automated process has detected that when you recently edited Candesartan, you added a link pointing to the disambiguation page Hydroxy.

(Opt-out instructions.) --DPL bot (talk) 07:53, 13 May 2025 (UTC)[reply]

Draft:McN-4187

Do you mind reviewing this article? I would, but I understand maybe three words of it. Thank you! GoldRomean (talk) 18:19, 14 May 2025 (UTC)[reply]

Hi @GoldRomean: I don't have access to the reviewer tools, so it is somewhat inconvenient for me to review the article. The article in question has a single primary source. The only other source I could find is US 4649204 by the same author. Hence I don't think this article is particularly notable. Boghog (talk) 19:19, 14 May 2025 (UTC)[reply]

Thanks! I asked for your help because I saw you at WP:WikiProject Articles for creation/List of reviewers by subject. GoldRomean (talk) 13:08, 15 May 2025 (UTC)[reply]

Hmm. I thought that I lost access to the AFCH tools due to inactivity in the project, but apparently I still do have access to the tools. So that excuse no longer applies. So I should be able to continue reviewing articles. Cheers. Boghog (talk) 18:02, 15 May 2025 (UTC)[reply]

No worries, it was me asking you for a favor in the first place. Happy reviewing (if you wish to continue). Cheers, GoldRomean (talk) 18:57, 15 May 2025 (UTC)[reply]

Difluanazine

I think that we need to have a difluanazine page. I would only be able to submit a draft but since you have an account you could make the page if you want? Maybe i'll consider making a draft but the only literature reference I have to go by is a patent and the pubchem webpage. That's not usually sufficient data to get the draft accepted though. It's also in that book The Dictionary of Drugs : Chemical Data book by J. Elks, C. R. Ganellin that is sometimes used as a source for a reference.

Hi. I think this article would have serious notability issues. It was apparently first disclosed in a patent by Janssen in 1965 (NL6507312) claiming a broad list of activities (antiangiotensine, antihistamine, coronary vasodilator, central nervous system stimulant, anticarragenic, and local anesthetic activity.). I can't find anything more specific. NCI thesaurus lists it as a "CNS stimulant". C166419 None of the other standard databases list anything about its activities:

Extended content

Unless you can find something more specific about the use or activities of the compound, I don't think an article is justified. Cheers. Boghog (talk) 08:46, 17 May 2025 (UTC)[reply]

Disambiguation link notification for May 20

An automated process has detected that when you recently edited KIF23, you added a link pointing to the disambiguation page ATP.

(Opt-out instructions.) --DPL bot (talk) 07:54, 20 May 2025 (UTC)[reply]

Ropanicant

I created this draft but I need you to help me with it to get it accepted on to wikipedia. https://en.wikipedia.org/wiki/Draft:Ropanicant Many thanks in advance for your help. — Preceding unsigned comment added by 92.31.192.97 (talk) 16:20, 21 May 2025 (UTC)[reply]

^-- sock-evasion, probably deep into WP:3X if anyone cared to file the paperwork. DMacks (talk) 17:19, 21 May 2025 (UTC)[reply]

The topic looks notable (the drug has been evaluated in human clinical trials and supported by peer reviewed sources). Per WP:MEDRS, I have made a number of edits to remove hype and medical claims not supported by secondary sources. Hence I have accepted the draft. I will also check out the other edits this IP contributor has made. Boghog (talk) 05:38, 22 May 2025 (UTC)[reply]

Dazadrol

I still think it's important at this point that wikipedia has a page devoted to Dazadrol.

If you can help with the draft I made this would be greatly appreciated:

https://en.wikipedia.org/wiki/Draft:Dazadrol — Preceding unsigned comment added by 92.31.192.97 (talk) 11:57, 22 May 2025 (UTC)[reply]

@92.31.192.97: I have made a few edits to the draft. The reported pharmacological activity of dazadrol looks notable. However I question the notability of the synthesis section. I am inclined to accept the article, but without the synthesis section. Boghog (talk) 13:47, 22 May 2025 (UTC)[reply]

SIR-117

Thanks for helping me out with the dazadrol document. In addition to that I need help editing a SIR-117 draft: https://en.wikipedia.org/wiki/Draft:SIR_117 — Preceding unsigned comment added by 92.31.192.97 (talk) 16:58, 22 May 2025 (UTC)[reply]

The only peer reviewed publication that this compound appears in is compound #21 in PMID 4543291 and it is not even the most potent compound disclosed in that publication. Furthermore SIR-117 does not appear to be a neuroleptic tranquilizer, but rather a tricyclic antidepressant. This is not a notable drug. The synthesis of a non-notable drug is even less notable. Hence I would oppose moving this draft to main space. Boghog (talk) 18:45, 22 May 2025 (UTC)[reply]

AR-M 1000390

Ok accepted that wikipedia does not need a SIR-117 article at this stage.

I would like it from you if you are able to improve my AR-M 1000390 draft from a few months ago.

https://en.wikipedia.org/wiki/Draft:AR-M_1000390 — Preceding unsigned comment added by 92.31.192.97 (talk) 08:08, 23 May 2025 (UTC)[reply]

There was a pre-existing article, ARM390, which covers the same compound. Therefore, I have merged relevant content from Draft:AR-M_1000390 into ARM390. Boghog (talk) 08:51, 23 May 2025 (UTC)[reply]

4-Chlorophenylacetonitrile

Great that's good that there is a page to cover this compound.

Although most of the pages created thus far are for drugs, there are also some missing compounds that are chemical precursors and not actually drugs themselves. Here is an example of a page I am working on that has not yet been accepted:

https://en.wikipedia.org/wiki/Draft:4-Chlorophenylacetonitrile — Preceding unsigned comment added by 92.31.192.97 (talk) 13:18, 23 May 2025 (UTC)[reply]